Thyrocare Expands Northern India Footprint with Polo Labs Acquisition

Thyrocare has acquired Polo Labs, a leading pathology diagnostic company in Northern India. This strategic move strengthens Thyrocare's presence in the region and aims to provide improved diagnostic services by leveraging Polo Labs' extensive network and expertise.

Thyrocare, a prominent name in diagnostic and preventive healthcare in India, has signed a Business Transfer Agreement with Polo Labs Private Limited to acquire their pathology diagnostic business. This acquisition significantly bolsters Thyrocare's influence in Northern India, reinforcing its status as a leading entity in the Indian diagnostic industry.

Polo Labs, headquartered in Punjab, operates 14 laboratories across Punjab, Haryana, and Himachal Pradesh. Their extensive network and regional expertise make them a valuable asset for Thyrocare. Polo Labs currently serves a large client base and holds a strong market position in Northern India, playing a critical role in the region's healthcare system. This acquisition aligns with Thyrocare's strategic focus on augmenting diagnostic capabilities and expanding its reach nationwide. Integrating Polo Labs' network with Thyrocare's advanced diagnostic infrastructure aims to enhance service delivery, expedite turnaround times, and improve patient convenience.

Rahul Guha, MD & CEO of Thyrocare Technologies Ltd. & President of API Holdings, remarked, 'This strategic acquisition will boost our diagnostic capabilities and services, leveraging Polo Labs' extensive network in North India. We are committed to a seamless integration and anticipate significant growth and innovation from this acquisition. Together, we will provide exceptional diagnostic services to a broader customer base.' This acquisition underscores Thyrocare's dedication to growth, innovation, and excellence in healthcare. As the company continues to expand, it remains focused on delivering superior diagnostic services across India.

(With inputs from agencies.)